GMP IPO Watch logo GMP IPO Watch
Latest Updates

GMP IPO Watch Blog: IPO News, GMP Analysis and Market Insights

Read the newest IPO GMP updates, allotment insights, subscription trends, and stock market explainers from GMP IPO Watch.

Latest IPO and GMP coverage

Recent Articles

Vivid Electromech IPO Closing Today: A High-Voltage Data Center Play—Should You Charge In? Open IPO
8 min

Vivid Electromech IPO Closing Today: A High-Voltage Data Center Play—Should You Charge In?

Navi Mumbai’s Vivid Electromech wraps up its ₹130.54 crore IPO today, March 30, 2026. Specializing in electrical panels for data centers and metro projects, the company has seen its profits jump 400% in just two years. We break down the massive Day 3 subscription rush, the ₹555 price band, and why institutional investors are piling in.

Read Article Open IPO Archive IPO Details
Amir Chand Jagdish Kumar IPO Day 3: "Aeroplane" Rice Takes Flight—Steady Bids & Growth Outlook Open IPO
8 min

Amir Chand Jagdish Kumar IPO Day 3: "Aeroplane" Rice Takes Flight—Steady Bids & Growth Outlook

One of India’s top 3 basmati rice exporters, Amir Chand Jagdish Kumar, enters Day 3 of its ₹440 crore IPO. With a price band of ₹201–₹212 and a ₹7 GMP, the issue is already oversubscribed. We dive into the "Aeroplane" brand's strength, the subscription numbers, and whether the 43% EBITDA growth makes this a "Subscribe."

Read Article Open IPO Archive IPO Details
Vivid Electromech IPO Day 2: Powering Data Centers & Metros—Steady Bids for This SME Entry Open IPO
8 min

Vivid Electromech IPO Day 2: Powering Data Centers & Metros—Steady Bids for This SME Entry

Navi Mumbai’s Vivid Electromech is currently in the middle of its ₹130.54 crore IPO. Specializing in high-voltage and low-voltage electrical panels, the company has seen its profits jump 400% in just two years. We look at the Day 2 subscription trends, the ₹555 price band, and why the "Data Center" boom is their biggest tailwind.

Read Article Open IPO Archive IPO Details
Sai Parenteral’s IPO Day 3: A High-Premium Pharma Play—Steady Progress or Overvalued? Open IPO
8 min

Sai Parenteral’s IPO Day 3: A High-Premium Pharma Play—Steady Progress or Overvalued?

Hyderabad-based Sai Parenteral's enters the final stretch of its ₹409 crore IPO. With a price band of ₹372–₹392 and a focus on high-margin injectables, the company is pitching a massive growth story. However, with a ₹0 GMP and a high P/E ratio, we break down the Day 3 subscription and the "Long-Term vs. Listing Gain" debate.

Read Article Open IPO Archive IPO Details